jueves, 7 de noviembre de 2024

Sebastian Sattui on older adults with ANCA-associated vasculitis October 21, 2024 • The Lancet Group

https://thelancetrheumatology.buzzsprout.com/1907323/episodes/15936380-sebastian-sattui-on-older-adults-with-anca-associated-vasculitis?utm_campaign=update-lanrhe&utm_medium=email&_hsenc=p2ANqtz--1M-CGbFHCOMQhRohELh5lGiO6AlERrJnVzqG6e2OGj2IrOuchbU5gWiOyXc9gSkWRhkTuL4QYi3HFN8EXeA5vcq9-eg&_hsmi=332673160&utm_content=332651922&utm_source=hs_email

Calcium pyrophosphate deposition disease

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00122-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanrhe&utm_campaign=update-lanrhe&utm_medium=email&_hsenc=p2ANqtz-8Wq5g2bUn8IU7lA9BAfsJEeoThhnQmqNCH74hu6CJLOetwj7ktg6Hlfg9jmEHohVzkdXejbcM2jajLKKTsf_YOwg-22g&_hsmi=332673160&utm_content=332651922&utm_source=hs_email

Inclusion of pregnant populations in clinical trials in China: the ethical considerations

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00276-5/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz--E2cFpEBsh9-nalfD1f5CUBjKK1PPs1udWtNmCK7xGMuC1s8fJ_JDkZKbRuQ3WfX2UN0znpZTVs36no4fprEOeJ51f4A&_hsmi=332673160&utm_content=332651922&utm_source=hs_email

Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00187-5/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-_5w8WpmFRLDapQD8e1lof6bCWBoIftdDUFMfbzHtjQ32TGHVLOD-I1gvOLx1Uf3MayteRsrYW53VgkvqtoxEekjYIanA&_hsmi=332673160&utm_content=332651922&utm_source=hs_email

Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab George Bertsias,Jinoos Yazdany

https://www.thelancet.com/journals/lanrhe/issue/vol6no11/PIIS2665-9913(24)X0011-9

Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00194-2/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz--XUGj_xb2-rHmOfJnXWpImbbcaKMTCE5UkhRcSiXH2FiDmGVpxnmWFN-vbw7nI_a9iU-rkl7qHq6EFOJPYSgpNar53ZQ&_hsmi=332673160&utm_content=332651922&utm_source=hs_email

NCCIH 25th Anniversary Celebration: Exploring the Impact of Whole Person Health Date: December 2, 2024 - 1:00 p.m. ET to 4:30 p.m. ET Virtual or Lipsett Amphitheater, Building 10, NIH Campus

https://www.nccih.nih.gov/news/events/nccih-25th-anniversary-celebration-exploring-the-impact-of-whole-person-health?nav=govd